SensoLyte® Green PIN1 Activity Assay Kit Fluorimetric - 1 kit

Check your price
  • Cat.Number : AS-72240
  • Availability :
    In stock
  • Shipping conditions : Ice fees will apply


Peptidyl-prolyl isomerase (PPIase) Pin1 catalyzes cis/trans isomerization of the phospho- Serine/Threonine-Proline peptide bonds. Pin1 consists of short N-terminal protein-protein interaction domain that allows enzyme to bind phosphoproteins and longer C-terminal izomerase domain. Pin1 has many biological substrates, plays critical role in cell-cycle regulation, and up-regulated in many human cancers. Recently, Pin1 was linked to the Alzheimer’s disease pathogenesis. Pin1 can bind phosphorylated Thr-212/231 residues of Tau protein and increase its deposphorylation that may prevent formation of Tau neurofibrilary tangles.
The SensoLyte® Green Pin1 Assay Kit uses fluorogenic substrate that was pretreated to convert into cis isoform. Pin1 changes substrate into trans conformation that is readily cleaved to generate fluorescent signal which can be monitored at Ex/Em=490/520nm. Increase in fluorescence intensity is directly proportional to the Pin1 activity.


Kits components
  • Component A: Pin1 Green Substrate: 0.1 mM , 60 µL Component B: Pin1, Human Recombinant: 1 mg/ml, 10 µL Component C: Pin1 Developer, 100X: 50 µL, 4 vials Component D: Assay Buffer: 30 mL Component E Pin1 Inhibitor 50mM in DMSO, 25 µL
Absorbance (nm)
  • 490
Emission (nm)
  • 520
Storage & stability
Storage Conditions
  • Store component B at -80°C. Store all other components at -20°C. Component D can be stored at room temperature for convenience. Protect component A from light and moisture.
Biomarker Target
Detection Method
Research Area
Sub-category Research Area
  • Research use

You may also be interested in the following product(s)


Epigallocatechin-gallate Suppresses Tumorigenesis by Directly Targeting Pin1

Cancer Prev Res . 2011 Sep 01 ; 4(9) 1366 | DOI : 10.1158/1940-6207.CAPR-11-0301

  • D.V. Urusova
  • et al

Pin1 inhibitors: Pitfalls, progress and cellular pharmacology

Biorg Med Chem Lett . 2013 Aug 01 ; 23(15) 4283 | DOI :

  • JD. Moore
  • A. Potter